Latest Regulatory News

Proteomics International Laboratories has secured a $2.2 million Australian Government R&D tax rebate, reinforcing its financial position as it advances a promising pipeline of diagnostic tests based on its proprietary Promarker® technology.

CVC Limited has announced an offer of $50 million in redeemable, unsecured notes (CVC Notes 3), combining a New Money Offer and a Reinvestment Offer for existing CVCHA holders. The notes will pay floating quarterly interest and are expected to be listed on the ASX under code CVCHB.

Pathkey.AI has teamed up with Armstrong Clinical to blend AI-driven trial predictions with expert clinical strategy, aiming to boost early-phase trial success and accelerate drug development in Australia and beyond.

Strickland Metals has reported its largest-ever mineralised intercept at the Gradina Deposit in Serbia, with over 700 metres of continuous gold and zinc mineralisation. This breakthrough supports confidence in expanding the Rogozna Project’s resource ahead of a maiden estimate due late 2025.

Aristocrat Leisure reported robust FY25 results with revenue up 11% to $6.3 billion and a 12% rise in normalised net profit after tax before amortisation. The company boosted dividends by 19% and completed key acquisitions and divestitures, positioning itself for future growth.

Pantera Lithium has identified seven priority exploration targets at its Gillham Silver-Antimony Project in Arkansas, marking the first modern evaluation of this historic mining district in over a century. The move aligns with growing US strategic focus on critical minerals like antimony and silver.

Mineral Resources Limited and POSCO Holdings have agreed to form a $1.2 billion joint venture for their lithium assets, marking a significant step in global lithium supply partnerships. The deal will strengthen MinRes’ balance sheet and deepen ties between Australia and Korea in critical minerals.

Marimaca Copper's Chilean subsidiary has obtained formal environmental approval for its Marimaca Oxide Project, clearing a critical hurdle toward construction readiness in the second half of 2026. This milestone follows years of environmental and social groundwork and sets the stage for the next permitting phase.

First Graphene has extended its partnership with Breedon Group to October 2026 following successful trials of graphene-enhanced cement that improved strength by up to 35% and reduced CO2 emissions by 15%.

Vectus Biosystems has responded to an ASX price query following a dramatic spike in its share price and trading volume, denying any undisclosed information and confirming compliance with ASX rules.

DGL Group has addressed ASX concerns following a disclaimer of opinion in its FY25 audit, citing inventory valuation issues and a fraud incident. The company outlines ongoing remediation efforts including ERP system migration and enhanced controls.

Monash IVF Group has appointed Dr Victoria Atkinson as its new Managing Director and CEO, effective May 2026, signaling a strategic leadership shift for the assisted reproductive services provider.